iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMeans Investment Co., Inc.
Latest Disclosed Ownership5,588 shares
Latest Disclosed Value $ 943,583
Means Investment Co., Inc. ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 24, 2026 - Means Investment Co., Inc. filed a 13F-HR form disclosing ownership of 5,588 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $943,583 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 5,754 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -2.88% during the quarter. The current value of the position is $732,307 USD.

Means Investment Co., Inc. has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,588 -166 -2.88 944 -2.88 0.0822
2026-01-26 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,754 -323 -5.32 971 10.72 0.0818
2025-11-06 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,077 -506 -7.69 877 5.41 0.0759
2025-07-25 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,583 -2,740 -29.39 833 -30.20 0.0789
2025-04-21 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,323 -997 -9.66 1,192 -12.61 0.1266
2025-01-24 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,320 914 9.72 1,364 -0.37 0.1420
2024-10-18 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,406 -137 -1.44 1,370 4.58 0.1522
2024-07-19 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,543 -612 -6.03 1,310 -6.03 0.1566
2024-04-17 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,155 16 0.16 1,393 1.16 0.1803
2024-01-25 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,139 -2,447 -19.44 1,377 -10.53 0.1985
2023-10-25 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,586 -269 -2.09 1,539 -5.70 0.2520
2023-07-31 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,855 518 4.20 1,632 2.45 0.2583
2023-05-08 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,337 549 4.66 1,593 2.97 0.2799
2023-01-27 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,788 484 4.28 1,548 17.02 0.3102
2022-10-17 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,304 1,444 14.65 1,322 13.97 0.2868
2022-07-21 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,860 1,326 15.54 1,160 4.32 0.2459
2022-04-26 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,534 1,003 13.32 1,112 -3.22 0.2013
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,531 3,544 88.89 1,149 78.14 0.2029
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,987 -1,294 -24.50 645 -25.35 0.1274
2021-08-10 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,281 157 3.06 864 12.06 0.1728
2021-04-05 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,124 378 7.96 771 -4.34 0.1754
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,746 817 20.79 806 48.98 0.1838
2020-11-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,929 309 8.54 541 13.42 0.1487
2020-08-13 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,620 59 1.66 477 8.41 0.1495
2020-04-23 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,561 359 11.21 440 12.82 0.1703
2020-01-21 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,202 3 0.09 390 11.43 0.1307
2019-11-05 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,199 -566 -15.03 350 -14.63 0.1321
2019-08-07 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,765 67 1.81 410 -0.73 0.1682
2019-04-16 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,698 890 31.70 413 52.40 0.1814
2019-04-16 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,808 2,808 271 0.1500
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Call 2,200 -47.62 2 -66.67 n/a n/a n/a
2020-08-13 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Call 4,200 6 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.